Biogazelle is a innovative bioanalytical services company specializing in high-value applications that significantly improve the success of pharmaceutical drug development. To support the development of small molecules, RNA targeted drugs, and adoptive cell therapies, we apply a suite of genomic and transcriptomic technologies, to find and validate RNA biomarkers, and to assess safety, toxicity, and efficacy. Biogazelle holds a unique forefront position in the application of quantitative PCR, digital PCR and dedicated RNA sequencing workflows on precious clinical samples such as liquid biopsies and FFPE tissues. We perform our services in an ISO17025 accredited and GCLP-compliant laboratory delivering high quality data to support research, clinical trials and diagnostic test development. Our team combines scientific excellence with agile project management in an open communication spirit. We regard our customers as partners and their projects as our projects.
